Artemis Hospital has completed more than 2,500 CyberKnife radiosurgery procedures, marking a significant milestone in its advanced cancer and neurosurgical treatment programme. The achievement reflects the hospital’s growing experience in delivering precision, minimally invasive care for patients with complex tumors and neurological disorders.
The hospital has also strengthened its treatment capabilities by installing North India’s first M6 CyberKnife equipped with VOLO™ technology. The latest robotic radiosurgery platform is designed to improve treatment accuracy, shorten procedure times, and enhance patient comfort. Using real-time imaging, robotic beam delivery, and automatic motion tracking, the system can continuously adjust treatment for tumors that move during breathing or are located close to critical organs. Its advanced planning software also helps create highly precise radiation plans while reducing treatment duration.
The CyberKnife programme at Artemis Hospital is led by Dr. Aditya Gupta, Chairman – Neurosurgery & CNS Radiosurgery and Co-Chief, CyberKnife Centre, whose team has been providing non-invasive treatment for a broad range of neurological and oncological conditions.
Speaking on the achievement, Dr. Gupta said,
“Crossing the milestone of 2,500 CyberKnife procedures is a proud moment for our entire team and a reflection of the trust patients have placed in us. Every case represents a life that has benefited from precision medicine and multidisciplinary expertise. CyberKnife has revolutionized the way we manage several complex neurological and oncological conditions by enabling us to deliver sub-millimetre accuracy while preserving healthy surrounding tissue. For many patients, this technology has made it possible to avoid open surgery, prolonged hospitalization, and the complications associated with conventional treatment.”
CyberKnife differs from conventional radiation therapy by delivering highly focused radiation without the need for surgical incisions. In most cases, patients do not require general anaesthesia or rigid head frames during treatment. The robotic system delivers radiation from multiple angles while automatically compensating for even slight patient or tumor movement. This enables specialists to treat lesions in sensitive locations—including the brainstem, skull base, and spine—while limiting radiation exposure to surrounding healthy tissue.
According to the hospital, the technology has been used to treat a wide variety of conditions, including benign and malignant brain tumors, metastatic brain lesions, spinal tumors, arteriovenous malformations, trigeminal neuralgia, recurrent cancers, and selected tumors affecting the prostate, lungs, liver, and pancreas. Each case is assessed by a multidisciplinary team to develop an individualized treatment strategy based on the patient’s clinical condition.
Dr. Gupta further added,
“Our vision has always been to make world-class radiosurgery accessible to patients in India while continuously adopting the most advanced technologies available globally. The addition of the M6 CyberKnife with VOLO marks the beginning of a new chapter in precision radiation treatment. Combined with our team’s experience of over 2,500 successful procedures and thousands of complex brain surgeries, we are able to offer highly personalized treatment strategies that maximize effectiveness while preserving patients’ quality of life.”
The hospital said the combination of experienced specialists and next-generation radiosurgery technology has enabled it to expand treatment options for patients with difficult-to-treat tumors involving the brain, spine, head and neck, lungs, liver, prostate, and other critical anatomical sites.
The milestone of more than 2,500 CyberKnife radiosurgery procedures highlights Artemis Hospital’s continued focus on precision medicine and minimally invasive treatment. Backed by advanced technology and multidisciplinary expertise, the hospital aims to further improve outcomes while providing patients with safer and more personalized care for complex neurological and cancer-related conditions.
(Photo courtesy: facebook/Dradityaguptaofficial)